Analystreport

Immune Design Corp (NASDAQ: IMDZ) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

IMMUNE DESIGN CORP COMMON STOCK  (IMDZ) 
Last immune design corp common stock earnings: 11/6 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.immunedesign.com/investor-relations